The global organ preservation market size was valued at USD 198.87 Million in 2024, and it is expected to reach USD 320.40 Million by 2033, exhibiting a growth rate (CAGR) of 5.39% from 2025 to 2033.
To get more information on this market, Request Sample
Increasing rates of chronic diseases create a high demand for organ transplantation, thereby propelling the growth in the market. Chronic diseases include diabetes, hypertension, and kidney diseases that can cause organs to fail. Increasing cases of such diseases will thus require the organs to be transplanted. Proper organ preservation is important in the maintenance of health and viability during transport and storage. Organ preservation ensures the continued functionality of organs during the transportation and storage periods to make a successful transplantation. Improving the methods for preserving organs addresses the shortage of donor organs for the treatment of chronic diseases among patients. They ensure better transplant outcomes and assist in improving patients' quality of life. Chronic obstructive pulmonary disease (COPD), a lung disorder, is also contributing to this trend, as it often leads to the need for lung transplants.
The rising investments in research and development (R&D) activities are fostering innovations in preservation techniques and solutions. As the need for organ transplants continues to grow, significant investments are being directed towards enhancing the viability and longevity of preserved organs. This funding supports the development of advanced preservation methods, such as hypothermic perfusion and normothermic perfusion. They help to maintain organ functionality for longer periods and reduce the risk of organ rejection. R&D efforts are also focused on creating new preservation solutions, such as bioengineered organs and cell-based preservation fluids, to enhance organ transport and storage facilities. Furthermore, they are leading to the formation of more efficient and safer technologies, including temperature-controlled storage systems, artificial intelligence (AI)-driven monitoring tools, and smart transport containers that ensure optimal preservation conditions. In April 2024, Vivalyx, a life-science startup, secured €5.4 Million Seed round for its innovative organ preservation solution. The company aims to reduce the threat to organs due to fluctuations in temperature. These funds will be utilized to support the essential clinical trials needed for regulatory approval and to initiate commercialization.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounts for the largest market share driven by its advanced healthcare infrastructure, increasing healthcare investments, and rising awareness about organ donation.
North America is enjoying the leading position in the market due to its advanced healthcare infrastructure, effective organ donation programs, and high awareness among the masses about organ transplantation. The region is noted for its innovations in preservation techniques, with strong support from government agencies and private organizations. A well-established network of organ banks and transplant centers also contributes significantly. Additionally, there is a high prevalence of chronic diseases leading to organ failure in the US, which drives consistent demand for preservation solutions. As per the data published on the official website of the Health Resources Services Administration (HRSA), as of September 2024, 89,792 patients that require kidney transplants and 9434 patients in need of liver transplants in the United States are part of the waiting list. This organ scarcity emphasizes the critical need for effective preservation techniques to extend the viability of organs during storage and transportation.
The Asia-Pacific region accounts for a sizeable portion of the organ preservation industry owing to the increasing organ failure cases and improving healthcare access. Government agencies in countries like India, China, and Japan promote organ donation programs and fund transplant activities, which require organ preservation solutions. Additionally, healthcare settings and organ banks adopt modern preservation techniques and wager on developing better healthcare infrastructure.
The market for organ preservation is expanding gradually in Europe, which can be attributed to its developed healthcare systems and the rising emphasis on organ transplantation. This area has strong organ donation programs supported by initiatives that raise awareness among the public. Countries like Germany, the UK, and Spain lead in innovative preservation technologies and specialized transplant facilities. Moreover, collaborations between medical institutions and R&D organizations promote improvements in preservation techniques.
On account of the improving healthcare facilities and the growing focus on organ donation awareness, Latin America is experiencing organ preservation market expansion. Nations, such as Brazil and Mexico emphasize initiatives that expand transplant networks. Increasing financing of healthcare infrastructure, in confluence with partnerships with big organizations, contribute to technological advancements in preservation methods.
The market for organ preservation in the Middle East and Africa region is distinguished by the growing healthcare investments and awareness campaigns. Countries like Saudi Arabia and South Africa focus on developing transplant programs and increasing donor registrations. In this region, there is a high number of improved healthcare facilities that help to introduce advanced preservation solutions. Here, hospitals work on expanding their organ transplantation and preservation capabilities.
Some of the leading organ preservation market companies include 21st Century Medicine Inc., Biolife Solutions Inc., Bridge to Life Ltd., Bristol-Myers, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals LLC, Lifeline Scientific Inc., OrganOx Ltd., Paragonix Technologies Inc., Transmedics, Inc., Waters Medical Systems LLC, Xvivo Perfusion, among many others. In November 2024, OrganOx Ltd., the well-known organ & tissue donor service in the United Kingdom, teamed up with eGenesis, Inc., the prominent biotechnology company that develops human compatible organs and cells, to create a liver support system that facilitates liver recovery in the acute setting. This solution inculcates a leading organ preservation platform and utilizes normothermic machine perfusion (NMP) technology to cure patients with liver failure.
Report Features | Details |
---|---|
Market Size in 2024 | USD 198.87 Million |
Market Forecast in 2033 | USD 320.40 Million |
Market Growth Rate 2025-2033 | 5.39% |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Preservation Solutions Covered | UW Solution, Custodiol HTK, Perfadex, Others |
Organ Donation Types Covered | Living Organ Donation, Deceased Organ Donation |
Techniques Covered | Static Cold Storage Technique, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others |
Organ Types Covered | Kidney, Liver, Lung, Heart, Others |
End-Users Covered | Hospitals and Clinics, Organ Banks, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 21st Century Medicine Inc., Biolife Solutions Inc., Bridge to Life Ltd., Bristol-Myers, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals LLC, Lifeline Scientific Inc., OrganOx Ltd., Paragonix Technologies Inc., Transmedics, Inc., Waters Medical Systems LLC, Xvivo Perfusion., etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |